Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001104659-21-140219

Chief Executive Officer acquired 353,450 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Hively Brad · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2021-01-12 Grant or award : show line 1 in the form +141,380 141,380 D
2021-01-12 Grant or award : show line 2 in the form +212,070 212,070 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-11-12 Grant or award : show line 3 in the form Stock Options (right to buy) +993,460 D
2021-11-12 Grant or award : show line 4 in the form Stock Options (right to buy) +823,971 D
Loading xslF345X03/tm2132979-10_4seq1.xml…